Trial Profile
Stereotactic Radiosurgery and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer (Protocol Number GK001)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 May 2022
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Cisplatin (Primary) ; Docetaxel (Primary) ; Paclitaxel (Primary) ; Pemetrexed (Primary)
- Indications Non-small cell lung cancer; Squamous cell cancer
- Focus Adverse reactions; Therapeutic Use
- 31 May 2020 Status changed from recruiting to completed, according to results presented at the 56th Annual Meeting of the American Society of Clinical Oncology.
- 31 May 2020 Results assessing the role of stereotactic body radiosurgery (SBRT) along with full dose systemic chemotherapy in the treatment of unresectable stage 2 and stage 3 NSCLC, were presented at the 56th Annual Meeting of the American Society of Clinical Oncology.
- 30 Jan 2017 Planned End Date changed from 1 Oct 2016 to 1 Oct 2017.